Neurológiai Osztály: Dr. Jakab Gábor

Dr. Jakab Gábor

Közlemények:

  1. Komoly, S., Jakab, G. and Fazekas, A., Multiple sclerosis: failure of treatment with verapamil in a pilot trial, J Neurol, 233 (1986) 59‑60. (1,849)
  2. Major, O. and Jakab, G., The effect of sodium pentosulfat (SP‑54) on experimental brain edema, Neuroscience, Supplement #2 (1987) S563. (Abstract)
  3. Jakab, G., Réthelyi, M. and Salamon, I., Neuropeptides in the post mortem human spinal cord, Clin Neuropath, 7 (1988) 173. (Abstract)
  4. Jakab, G., Bártfai, Z., Salamon, I. and Réthelyi, M., Comparison of the termination patterns of the CGRP‑immunoreactive primary afferent fibers in the dorsal horn of human and rat spinal cord, European Journal of Neuroscience, Supplement #2 (1989) 206. (Abstract)
  5. Fazekas, A., Györfi, A., Pósch, E., Jakab, G., Bártfai, Z. and Rosivall, L., Effect of the transection of inferior alveolar nerve on inflammation of alveolar mucosa in rat, Proc Hung Physiol Sci, 55 (1990) 49. (Abstract)
  6. Györfi, A., Fazekas, A., Irmes, F., Jakab, G., Bártfai, Z. and Rosivall, L., Role of substance P in the development of neurogenic inflammation of alveolar mucosa in rat, Proc Hung Physiol Sci, 55 (1990) 70. (Abstract)
  7. Jakab, G., Salamon, I., Bártfai, Z., Györfi, A. and Rosivall, L., The distribution of calcitonin gene‑related peptide‑immunoreactive fibers in the gastric wall under normal conditions and in stress ulcer induced by "cold restraint" in rat, Digestive Diseases and Sciences, 35 (1990) 1019. (Abstract)
  8. Jakab, G., Salamon, I., Petrusz, P. and Réthelyi, M., Termination patterns of calcitonin gene‑related peptide‑immunoreactive nerve fibers in the dorsal horn of the human spinal cord, Exp Brain Res, 80 (1990) 609‑617. (2,227)
  9. Jakab, G., Komoly, S. and Juhász, E., Herpes zoster infection with acute urinary retention, Orv. Hetil., 131 (1990) 529‑530.
  10. Jakab, G., Salamon, I., Bártfai, Z. and Rosivall, L., The distribution patterns of calcitonin gene‑related peptide‑immunoreactive fibers in the rat skin and gastric mucosa, European Journal of Neuroscience, Supplement No.3. (1990) 236. (Abstract)
  11. Fazekas, A., Györfi, A., Pósch, E., Jakab, G., Bártfai, Z. and Rosivall, L., [The effect of the transsection of the inferior alveolar nerve on neurogenic inflammation of the mouth mucosa. II. Immunohistochemical studies], Fogorv. Sz., 84 (1991) 59‑62.
  12. Fazekas, A., Györfi, A., Pósch, E., Jakab, G., Bártfai, Z. and Rosivall, L., Effect of denervation on the neurogenic inflammation of the rat mandibular mucosa, Naunyn Schmiedebergs Arch Pharmacol, 343 (1991) 393‑398. (2,813)
  13. Jakab, G., Salamon, I., Mezey, É., Rosivall, L. and Webster, H.deF., CGRP‑containing nerve fibers and cells in the gastric wall, Transactions of the American Society for Neurochemistry, 23 (1992) 284. (Abstract)
  14. Jakab, G., Pacak, K., Salamon, I., Rosivall, L. and Webster, H.deF., Neuronal and non‑neuronal origins of CGRP in the gastric wall, Society of Neuroscience Abstracts, 18 (1992) 265. (Abstract)
  15. Yao, D.L., Brenner, M., Komoly, S., Bondy, C., Jakab, G. and Webster, H., Astrocytic IGF‑I and GFAP messenger‑RNA and peptide expression during cuprizone‑induced demyelination and remyelination, J Neuropath Exp Neurol, 51 (1992) 338. (Abstract)
  16. Györfi, A., Fazekas, A., Irmes, F., Jakab, G., Sütő, T. and Rosivall, L., Role of substance P (SP) in development of symptoms of neurogenic inflammation in the oral mucosa of the rat, J Periodontal. Res, 28 (1993) 191‑196. (1,012)
  17. Jakab, G., Webster, H.D., Salamon, I. and Mezey, É., Neural and non‑neural origin of calcitonin gene‑related peptide (CGRP) in the gastric mucosa, Neuropeptides, 24 (1993) 117‑122. (2,026)
  18. Pacak, K., Yadid, G., Jakab, G., Lenders, J.W., Kopin, I.J. and Goldstein, D.S., In vivo hypothalamic release and synthesis of catecholamines in spontaneously hypertensive rats, Hypertension, 22 (1993) 467‑478. (4,839)
  19. Jakab, G., Szallasi, A. and Agoston, D.v., The calcitonin gene‑related peptide (CGRP) phenotype is expressed early and up‑regulated by resiniferatoxin (RTX) in mouse sensory neurons, Dev Brain Res, 80 (1994) 290-294 (2,207)
  20. Lehel, C., Olah, Z., Jakab, G., Szallasi, Z., Blumberg, P.M. and Anderson, W.B., Intracellulare localization and biological effects of different domain fragments of protein kinase C‑epsilon overexpressed in NIH 3T3, J Cell Biochem, Supplement 18D (1994) 85. (2,849) (Abstract)
  21. Olah, Z., Lehel, C., Jakab, G. and Anderson, W.B., Construction and application of a novel intercompatible epitope tagging system to characterize PCR fragments expressed in E. coli and mammalian cells, Anal Biochem, 221 (1994) 94-102 (2,313)
  22. Lehel, C., Olah, Z., Jakab, G., Szallasi, Z., Blumberg, P.M. and Anderson, W.B., Overexpressed Zinc‑finger domain of protein kinase C epsilon is localized to the Golgi and inhibits cell growth, PNAS, 92 (1995) 1406-1410 (10,244)
  23. Lehel, C., Oláh, Z., Jakab, G., Szallasi, Z., Petrovics, G., Harta, G,. Blumberg, P.M. and Anderson, W.B., Protein Kinase C epsilon Subcellular Localization Domains and Proteolytic Degradation Sites. J. Biol Chem, 270 (1995) 19651-19658 (7,452)
  24. Jakab, G., Principles of the treatment of Multiple sclerosis (Hungarian), Gyógyszereink 45 (1995) 166-170
  25. Lehel, C., Oláh, Z., Petrovics, G., Jakab, G., and Anderson, W.B. Influence of Various Domains of Protein Kinase C epsilon on its PMA-Induced Translocation from the Golgi to the Plasma Membrane, Biochem Biophys Res Com 223 (1996) 98-103 (2,872)
  26. Szirmai, I., Jakab, G., Neurológical disorders, (chapter), Molecular Medicina, ed.: Kopper, Marcsek, and Kovalszky, Medicina Publishing Corp., Budapest, (1997) 228-243
  27. Jakab, G. Treatment of Multiples sclerosis (Hungarian), Praxis 7 (1998) 11-18
  28. Horváth, R., Horváth, J., Kiss, G., Jakab, G. Sági, I., Solymosi, D., Karcagi, V., Komoly, S., Association of DNA mutations and central nervous system symptoms in Leber’s disease. (Hungarian) Clin Neurosci / Ideggy Szle  51 (1-2) (1998) 49-54
  29. Tárczy, M., Takáts, A., Arányi, Zs., Jakab, G., Kapócs, G., Gönczi, G., Szombathelyi, É., Diagnostic value of Apomorphin test and imaging techniques in Parkinson’s syndrome. (Hungarian) Clin Neurosci / Ideggy Szle  52 (3-4) (1999) 82-86
  30. Tatár, G., Jakab, G., Scientific basis and practical aspects of pain management. Hungarian), Háziorvosi Továbbképző Szemle  4 (1999) 378-382
  31. Jakab, G., New aspect of the treatment of Multiple sclerosis, (Hungarian) Kórház 2000/1: 17-18
  32. Baintner, K., Jakab, G., Győri, Zs., Kiss, P., Binding of FITC-Labelled Lectins to the Gastrointestinal Epithelium of the Rat, Pathology Oncology Research 6 (2000) 179-183
  33. Mayer, I., Jakab, G., Pathology and therapy of Alzheimer’s disease (Hungarian),  Medicus Anonymus, Supplement 2001.3:28-31
  34. Baintner, K., Jakab, G., Győri, Zs., Kiss, P., In vitro binding of FITC-labelled plant lectins to gasrtointestinal cells in the hen (Gallus domesticus), Acta Agraria Kaposváriensis, 5 (2001) 2:47-53
  35. Jakab, G., Multiple sclerosis, Trigeminal neuralgia (chapters in Hungarian) in Encyclopedia of the diseases, Springer-Vitalitas Ltd. (2002) 792, 808
  36. P. Johannsen, H. Hampel, S. Hasselbalch, G. Jakab, I. Kloszewska, J. McCarthy, P. Sakka, E. Triau, C. Wouters, S. Qvitzau, Y. Xu, E. Schwam, S. Richardson, R. Schindler (Aarhus, DK; Munich, D; Copenhagen, DK; Budapest, HUN; Lodz, PL; South Yarmouth, USA; Athens, GR; Leuven, B; Den Bosch; Ballerup, DK; New York; Teaneck, USA),  Cognition is physicians' main indicator of treatment efficacy in Alzheimer's disease patients  (Poster at the 13th Meeting of the European Neurological Society 2003. June 14-18. Istanbul, Turkey (P475) J Neurol 250 (2003) Suppl. 2. 126
  37. G. Jakab on behalf of the Copaxone Follow-up Study Group Follow-up study of multiple sclerosis patients treated with glatiramer acetate. J Neurol vol: 250 Suppl. 2. May 2003 p174
  38. G. Jakab, R. Oláh, Diagnosis of  Multiple Sclerosis (chapter) in: Vécsei L., Komoly S. (ed.) Sclerosis multiplex, Therapia Kiadó, Budapest, 2003, 46-67. o.
  39. G. Jakab, [Guidelines for comprehensive therapy in multiple sclerosis] Orv Hetil. 2004 Aug 1;145(31):1629-31. Review
  40. G. G. Kovacs, R. Hoftberger, K. Majtenyi, R. Horvath, P. Barsi, S. Komoly, H. Lassmann, H. Budka, and G. Jakab, Neuropathology of white matter disease in Leber's hereditary optic neuropathy Brain, January 1, 2005; 128(1): 35 - 41.
  41. Karussis D, Biermann LD, Bohlega S, Boiko A, Chofflon M, Fazekas F, Freedman M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Miller A; the International Working Group for Treatment Optimization in MS. A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting. Eur J Neurol. 2006 Jan;13(1):61-71.
  42. Goodin DS, Biermann LD, Bohlega S, Boiko A, Chofflon M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Karussis D, Miller A, Pakdaman H, Selmaj K, Sharief M; International Working Group for Treatment Optimization in MS. Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis. Curr Med Res Opin. 2007 Nov;23(11):2823-32
  43. Jakab G; [Assessment of the clinical and MRI results of the FREEDOMS and TRANSFORMS phase III. clinical trials].: Ideggyogy Sz. 2012 May 30;65(5-6):207-8.
  44. Banati M, Csecsei P, Koszegi E, Nielsen HH, Suto G, Bors L, Trauninger A, Csepany T, Rozsa C, Jakab G, Molnar T, Berthele A, Kalluri SR, Berki T, Illes Z; Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system. Eur J Neurol. 2013 Jan 7. doi: 10.1111/ene.12072. [Epub ahead of print]

 

(Magyarázat:

7. Jakab, G., Salamon, I., Bártfai, Z., The distribution of calcitonin…  ® (Absztrakt)

8. Jakab, G., Salamon, I., Petrusz, P., Termination … ® eredeti közlemény

Cumulative impact factor: 43,626